» Articles » PMID: 40089607

Maternal Di(2-ethylhexyl) Phthalate Exposure Increases the Risk of Congenital Heart Disease in Mice Offspring

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2025 Mar 16
PMID 40089607
Authors
Affiliations
Soon will be listed here.
Abstract

Abstrct: BACKGROUD: Epidemiological data suggest that maternal occupational exposure to mixed phthalates comprising di(2-ethylhexyl) phthalate (DEHP) increases the risk of congenital heart disease (CHD). In this study, we used mice as an animal model to validate impact of first-trimester DEHP exposure on the risk of CHD in offspring, to elucidate the possible mechanisms and to provide a potential feasible intervention.

Methods And Results: Eight-week-old C57BL/6J pregnant mice were randomly divided into standard and DEHP diet groups. The incidence of CHD in DEHP diet group offspring was up to 14.41% observed via Hematoxylin-eosin (HE) staining. Quantitative PCR analysis revealed that expression of key genes involved in cardiogenesis were suppressed at the transcriptional level, which may be due to decreased nuclear translocation of p65. The inhibition of DEHP on key genes was rescued to some extent by choline through driving p65 into nuclear. In the mice, supplementation of choline during DEHP exposure reduced the incidence of CHD in offspring from 14.41% to 4.63%.

Conclusions: Our study demonstrates that mice first-trimester DEHP exposure significantly increases the risk of CHD in the offspring via inhibiting mRNA levels of key genes in cardiogenesis, and choline could protect against the pathogenesis.

Impact: Our study provides key mechanistic insights into the risk of CHD by DEHP exposure during early pregnancy, and provides choline as a potentially effective intervention. DEHP suppressed the expression of key genes involved in embryonic cardiac septum development at the transcriptional level via inhibiting nuclear translocation of p65. Choline can play a role in rescuing the inhibition of DEHP on cardiogenesis genes via driving p65 translocate into the nuclear.

References
1.
Liu Y, Chen S, Zuhlke L, Black G, Choy M, Li N . Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019; 48(2):455-463. PMC: 6469300. DOI: 10.1093/ije/dyz009. View

2.
Bruneau B . The developmental genetics of congenital heart disease. Nature. 2008; 451(7181):943-8. DOI: 10.1038/nature06801. View

3.
Lage K, Greenway S, Rosenfeld J, Wakimoto H, Gorham J, V Segre A . Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc Natl Acad Sci U S A. 2012; 109(35):14035-40. PMC: 3435181. DOI: 10.1073/pnas.1210730109. View

4.
Zaidi S, Brueckner M . Genetics and Genomics of Congenital Heart Disease. Circ Res. 2017; 120(6):923-940. PMC: 5557504. DOI: 10.1161/CIRCRESAHA.116.309140. View

5.
Wang C, Zhan Y, Wang F, Li H, Xie L, Liu B . Parental occupational exposures to endocrine disruptors and the risk of simple isolated congenital heart defects. Pediatr Cardiol. 2015; 36(5):1024-37. DOI: 10.1007/s00246-015-1116-6. View